Post

R

Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.

Natural transition orbitals revealed the charge-transfer character of the S1 state.

9:15:21 PM · Jul 9, 2026
Sign in to reply and join the conversation.